Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4918 total record number 290 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 401 out of 492
4918 citations found

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice

Griffiths, KL;Stylianou, E;Poyntz, HC;Betts, GJ;Fletcher, HA;McShane, H;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine

Iyer, V;Hu, L;Schant, CE;Vance, D;Chadwick, C;Jain, NK;Brey, RN;Joshi, SB;Volkin, DB;Andra, KK;Bann, JG;Mantis, NJ;Middaugh, CR;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Toxin A from Clostridium difficile

  • … On a separate plate, two – fold dilutions of Fab in serum – free media plus 400pM of native TcdA ( List Biological Laboratories, Inc., cat# 152B) was pre – incubated for 1 hour and then the mixture was added to the cells by media exchan ge. After 24 hours (when cell round ing in controls became evident), the media was changed to complete media (EMEM with serum). …

Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice

Glasser, SW;Maxfield, MD;Ruetschilling, TL;Akinbi, HT;Baatz, JE;Kitzmiller, JA;Page, K;Xu, Y;Bao, EL;Korfhagen, TR;

Product: LPS from Escherichia coli O111:B4

  • In Vivo Model of Recurrent LPS Exposure:

    Escherichia coli LPS type 0111:B4 (List Biologicals, Campbell, CA) was used for animal exposures. LPS was delivered by noninvasive oral aspiration, as described previously (13). Briefly, mice were lightly anesthetized and suspended by upper incisors on a 45-angle incline board. The tongue was extended with forceps and 100 l of LPS or PBS was placed into the oral cavity. Mice were monitored until fluid aspiration followed by several additional chest retractions was observed; 10 to 12 mice of each genotype were exposed for each end point. Mice were administered either a single 8-g dose of LPS to assess threshold sensitivity due to SP-C deficiency or were serially administered 8 g LPS interspaced by 2 days of recovery before the second and third doses. Mice were observed for 3, 5, or 30 days after the final LPS exposure before assessing recovery from injury. In a separate experiment, an SP-Cenriched surfactant extract was transiently replaced before LPS challenge. Mice were given a single 25-g dose of Survanta (Abbvie Inc., North Chicago, IL) as an exogenous source of SP-C before LPS exposure, and the cell counts and myeloperoxidase activity levels determined in the bronchoalveolar lavage fluid (BALF) 24 hours later as an indicator of neutrophil activity and cellular inflammation.

Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1 via caspase-8 in dendritic cells

Antonopoulos, C;El Sanadi, C;Kaiser, WJ;Mocarski, ES;Dubyak, GR;

Product: LPS from Escherichia coli O111:B4

  • Key reagents and their sources were as follows: Escherichia coli LPS serotype O1101:B4 (List Biological Laboratories),…

    Isolation, culture, and experimental testing of BMDC:

    For experimental tests, plated BMDC were centrifuged at 300 3 g for 510 min, and the differentiation medium was removed and replaced with low-serum DMEM (0.1% bovine calf serum plus penicillin, streptomycin, and L-glutamine). The cells were equilibrated for 15 min at 37C in 10% CO2 prior to addition of test reagents. BMDC were routinely primed with 1 mg/ml LPS (unless indicated otherwise) for 4 h to activate TLR4 signaling prior to treatment with indicated concentrations of Dox, STS, or other chemotherapeutic drugs for additional periods ranging from 2 to 18 h (with the LPS being present throughout).

Responses of different geographic populations of two potato tuber moth species to genetic variants of Phthorimaea operculella granulovirus

Zeddam, J;Lery, X;YanneryG-omez-Bonilla, ;Espinel-Correal, C;Paez, D;Rebaudo, F;L-opez-Ferber, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

ITE, a novel endogenous nontoxic aryl hydrocarbon receptor ligand, efficiently suppresses EAU and T-cell-mediated immunity

Nugent, LF;Shi, G;Vistica, BP;Ogbeifun, O;Hinshaw, SJ;Gery, I;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity

Williams, JL;Gatson, NN;Smith, KM;Almad, A;McTigue, DM;Whitacre, CC;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent

Lalor, SJ;Segal, BM;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer